Baxter has implemented new allocation levels for several U.S. IV product groups, effective Nov. 26, as part of recovery efforts at its North Carolina manufacturing site.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Baxter moves closer to 100% allocation levels for IV products
